Updated Approaches against SARS-CoV-2

DOI Web Site 1 Citations
  • Haiou Li
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Yunjiao Zhou
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Meng Zhang
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Haizhou Wang
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Qiu Zhao
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China
  • Jing Liu
    Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China

Description

<jats:p>Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a growing understanding of SARS-CoV-2 in virology, epidemiology, and clinical management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been officially approved due to the absence of adequate evidence. Scientists are racing to develop a treatment for COVID-19. Recent studies have revealed many attractive therapeutic options, even if some of them remain to be further confirmed in rigorous preclinical models and clinical trials.</jats:p>

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top